Arrhythmias & electrophysiologyResearch article

Multimodality Imaging and Pace-Mapping Patterns in Patients With Cardiac Sarcoidosis and Ongoing Inflammation Undergoing Ventricular Tachycardia Ablation

JACC Clin ElectrophysiolPublished

  • Study of patients with definite cardiac sarcoidosis (CS) and active inflammation referred for ventricular tachycardia (VT) ablation

Authors' conclusion

In patients with CS and active inflammation, most VT target sites were confined to LGE+ and FDG+ areas. VT exit sites were associated with FDG+ areas. Patients in whom only VT exit sites were identified had higher VT recurrences.

Study context

Population
Patients with definite cardiac sarcoidosis and active inflammation referred for VT ablation; PET and CMR findings registered to electroanatomic maps4 women, age 55 ± 11 years, ejection fraction 43% ± 14%
Participants
14 patients
Comparison
Patients in whom only VT exit sites were identified vs patients in whom both nonexit sites and exit sites for individual VTs were identified
  • only VT exit sites identifiedn = 6
  • both nonexit sites and exit sites identifiedn = 8

Main finding

As reported in the abstract

VT target sites identified

distinct VTs

43

VT target sites

59

Further findings

VT recurrence · follow-up time of 32 ± 33 months · higher VT recurrence rate with only VT exit sites identified

P = 0.01

Location of VT target sites

VT target sites in LGE+ areas
88%
VT target sites in fluorodeoxyglucose (FDG)+ areas
71%
LGE+ and FDG+ colocalized
59%

VT exit and nonexit sites

VT exit sites
42 of 59
nonexit sites
17 of 59
VT exit sites were associated with FDG+ areas

Original publication

Multimodality Imaging and Pace-Mapping Patterns in Patients With Cardiac Sarcoidosis and Ongoing Inflammation Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. Published 11 September 2026. doi:10.1016/j.jacep.2026.07.020

Summarised from the published abstract; every number is checked against it